ASHG expands year-round virtual education with genetic diagnosis and rare disease symposium
Meeting Announcement
ASHG will host the Genetic Diagnosis & Rare Disease Virtual Symposium on December 2–3, featuring 16 expert-led sessions on cutting-edge genomic technologies and rare disease diagnosis. The event offers interactive learning, up to six CME credits, and global access to innovations like long-read sequencing, RNA-Seq, and federated variant sharing.
Key takeaways
Smartphone stethoscopes, voice-detected heart failure, training using physical and virtual hearts, as well as early detection of cardiovascular disease using blood spots are among the innovations being presented at the first-ever ESC Digital & AI Summit.
Together with technology, healthcare, and innovation experts, the summit will address the challenges of implementing digital health solutions while maintaining ethical integrity.
New research is uncovering how medications targeting the glucagon-like peptide-1 (GLP-1) system affect brain circuits involved in nausea, thirst, and pleasurable behaviors. These findings will be presented at Neuroscience 2025, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Researchers are shedding light on neural mechanisms underlying the progression of Alzheimer's disease. These findings will be presented at Neuroscience 2025, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.